Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

STOCKS

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Best Biotech Stocks

Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

GILD AMGN VRTX BIIB ILMN REGN MRNA IQV BNTX

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Smart Score	Market Cap	P/E Ratio	Dividend Yield	Sector	Article	Follow
GILD Gilead Sciences	$91.86	7.52M	xxxxxxxxxxxxx	15 Buy 11 Hold 0 Sell Moderate Buy		$114.48B	1.04K	3.31%	Healthcare
AMGN Amgen	$270.62	2.91M	xxxxxxxxxxxxx	11 Buy 11 Hold 1 Sell Moderate Buy		$145.47B	35.09	3.28%	Healthcare
VRTX Vertex Pharmaceuticals	$463.73	1.10M	xxxxxxxxxxxxx	18 Buy 9 Hold 2 Sell Moderate Buy		$119.42B	-232.66	―	Healthcare
BIIB Biogen	$150.03	1.61M	xxxxxxxxxxxxx	13 Buy 11 Hold 0 Sell Moderate Buy		$21.86B	13.55	―	Healthcare
ILMN Illumina	$143.87	1.81M	xxxxxxxxxxxxx	8 Buy 7 Hold 1 Sell Moderate Buy		$22.82B	-14.39	―	Healthcare
REGN Regeneron	$731.30	696.99K	xxxxxxxxxxxxx	16 Buy 5 Hold 1 Sell Moderate Buy		$80.36B	18.10	―	Healthcare
MRNA Moderna	$41.83	4.86M	xxxxxxxxxxxxx	4 Buy 10 Hold 4 Sell Hold		$16.10B	-7.18	―	Healthcare
IQV IQVIA Holdings	$199.06	1.16M	xxxxxxxxxxxxx	18 Buy 3 Hold 0 Sell Strong Buy		$36.13B	26.11	―	Healthcare
BNTX BioNTech SE	$120.38	586.07K	xxxxxxxxxxxxx	13 Buy 4 Hold 0 Sell Strong Buy		$28.86B	-57.30	―	Healthcare

Performance Comparison

GILD

Gilead Sciences

91.86

14.68

19.02%

AMGN

Amgen

270.62

3.25

1.22%

VRTX

Vertex Pharmaceuticals

463.73

53.05

12.92%

BIIB

Biogen

150.03

-98.10

-39.54%

ILMN

Illumina

143.87

20.35

16.48%

REGN

Regeneron

731.30

-127.84

-14.88%

MRNA

Moderna

41.83

-44.18

-51.37%

IQV

IQVIA Holdings

199.06

-27.66

-12.20%

BNTX

BioNTech SE

120.38

18.18

17.79%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Palantir, Axon, MicroStrategy to be added to Nasdaq-100 index

Palantir, Axon, MicroStrategy to be added to Nasdaq-100 index

Nasdaq (NDAQ) announced the results of the annual reconstitution of the Nasdaq-100 Index, which will become effective prior...

17h ago

FDA Lifts Hold on BioNTech’s Key Cancer Trial

FDA Lifts Hold on BioNTech’s Key Cancer Trial

BioNTech SE ( ($BNTX) ) has provided an update. BioNTech SE has announced that the FDA has lifted...

1d ago

BioNTech says partial clinical hold on BNT316 study lifted

BioNTech says partial clinical hold on BNT316 study lifted

BioNTech (BNTX) said it has been informed by its partner OncoC4 that the Food and Drug Administration has...

1d ago

A Dissapointing Week for Dow Jones Industrial Average Puts It in the Red

A Dissapointing Week for Dow Jones Industrial Average Puts It in the Red

The Dow Jones Industrial Average is falling on Friday as it prepares to close out the week red...

2d ago

Iqvia price target lowered to $235 from $255 at BofA

Iqvia price target lowered to $235 from $255 at BofA

BofA lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps a Buy rating...

2d ago

Gilead announces positive CHMP opinion for seladelpar

Gilead announces positive CHMP opinion for seladelpar

Gilead (GILD) Sciences announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency...

2d ago

VOO ETF Update, 12/13/2024

VOO ETF Update, 12/13/2024 

How is VOO stock faring? The Vanguard S&P 500 ETF is down 0.49% in the past five days but has...

2d ago

Gilead appoints Dietmar Berger as Chief Medical Officer

Gilead appoints Dietmar Berger as Chief Medical Officer

Gilead (GILD) announced that Dietmar Berger will join the company on January 2, 2025, as Chief Medical Officer...

2d ago

Iqvia price target lowered to $261 from $265 at Truist

Iqvia price target lowered to $261 from $265 at Truist

Truist lowered the firm’s price target on Iqvia (IQV) to $261 from $265 and keeps a Buy rating...

3d ago

MicroStrategy Set to Leap into the Nasdaq 100

MicroStrategy Set to Leap into the Nasdaq 100

MicroStrategy ($MSTR) is on track to make a big leap this month, with expectations it will join the...

3d ago

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Gilead Sciences

Hold

Assigned

2024-12-13

Vertex Pharmaceuticals

Buy

Assigned

2024-12-12

IQVIA Holdings

Buy

Reiterated

2024-12-12

BioNTech SE

Buy

Assigned

2024-12-11

Amgen

Buy

Reiterated

2024-12-11

Illumina

Hold

Downgraded

2024-12-11

Moderna

Sell

Initiated

2024-12-10

Regeneron

Buy

Reiterated

2024-12-10

Biogen

Hold

Downgraded

2024-12-09

Gilead Sciences

Buy

Assigned

2024-12-12

Most Recent Earnings of Biotech Stocks

Gilead Sciences

Nov 06, 2024

Sep 01, 2024

1.53 / 2.02

1.72

Amgen

Oct 30, 2024

Sep 01, 2024

5.27 / 5.58

4.71

Vertex Pharmaceuticals

Nov 04, 2024

Sep 01, 2024

4.08 / 4.38

4.2

Biogen

Oct 30, 2024

Sep 01, 2024

3.77 / 4.08

2.95

Illumina

Nov 04, 2024

Sep 01, 2024

0.88 / 1.14

0.136

Regeneron

Oct 31, 2024

Sep 01, 2024

11.70 / 12.46

11.86

Moderna

Nov 07, 2024

Sep 01, 2024

-1.80 / 0.03

0.55

IQVIA Holdings

Oct 31, 2024

Sep 01, 2024

2.82 / 2.84

2.84

BioNTech SE

Nov 04, 2024

Sep 01, 2024

-1.61 / 0.85

1.9

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

IQVIA Holdings - Strong Buy, based on 21 analyst ratings, 18 Buy, 3 Hold, and 0 Sell.

BioNTech SE - Strong Buy, based on 17 analyst ratings, 13 Buy, 4 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $91.86, and its average 12-month price target is $98.14.

Amgen's stock price is currently $270.62, and its average 12-month price target is $339.83.

Vertex Pharmaceuticals's stock price is currently $463.73, and its average 12-month price target is $518.46.

Biogen's stock price is currently $150.03, and its average 12-month price target is $246.90.

Illumina's stock price is currently $143.87, and its average 12-month price target is $163.56.

Regeneron's stock price is currently $731.30, and its average 12-month price target is $1,098.62.

Moderna's stock price is currently $41.83, and its average 12-month price target is $62.31.

IQVIA Holdings's stock price is currently $199.06, and its average 12-month price target is $250.75.

BioNTech SE's stock price is currently $120.38, and its average 12-month price target is $142.32.

Which Biotech stocks pay dividends?

Gilead Sciences does not currently pay dividends.

Amgen currently pays a dividend of $2.38 which represents an annual dividend yield of 3.28%. Amgen's next Ex-dividend date is February 14, 2025 and its next payout date is March 7, 2025.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.